This study employed focus group interviews (FGIs) to evaluate the preparedness and training requirements for an emerging infectious disease response system in the Republic of Korea.Based on the FGIs, the critical role of interdepartmental cooperation in responding to emerging infectious diseases was identified, with agencies such as public health centers, police, and fire services playing key roles in scene control, decontamination, and patient transport. Frequent staff turnover and a lack of trained personnel at local government levels were significant challenges, necessitating the development of training materials for unskilled workers. Civil complaints, common during outbreaks, require public officials to be educated on legal frameworks and the management of patients’ rights. The absence of standardized procedures for managing patients, such as bed assignments considering underlying conditions and sample collection, underscores the need for comprehensive guidelines.Interviewees emphasized cross-departmental training, detailed manuals, and legal education to improve infectious disease response capabilities.

This study employed focus group interviews (FGIs) to evaluate the preparedness and training requirements for an emerging infectious disease response system in the Republic of Korea.Based on the FGIs, the critical role of interdepartmental cooperation in responding to emerging infectious diseases was identified, with agencies such as public health centers, police, and fire services playing key roles in scene control, decontamination, and patient transport. Frequent staff turnover and a lack of trained personnel at local government levels were significant challenges, necessitating the development of training materials for unskilled workers. Civil complaints, common during outbreaks, require public officials to be educated on legal frameworks and the management of patients’ rights. The absence of standardized procedures for managing patients, such as bed assignments considering underlying conditions and sample collection, underscores the need for comprehensive guidelines.Interviewees emphasized cross-departmental training, detailed manuals, and legal education to improve infectious disease response capabilities.

This study employed focus group interviews (FGIs) to evaluate the preparedness and training requirements for an emerging infectious disease response system in the Republic of Korea.Based on the FGIs, the critical role of interdepartmental cooperation in responding to emerging infectious diseases was identified, with agencies such as public health centers, police, and fire services playing key roles in scene control, decontamination, and patient transport. Frequent staff turnover and a lack of trained personnel at local government levels were significant challenges, necessitating the development of training materials for unskilled workers. Civil complaints, common during outbreaks, require public officials to be educated on legal frameworks and the management of patients’ rights. The absence of standardized procedures for managing patients, such as bed assignments considering underlying conditions and sample collection, underscores the need for comprehensive guidelines.Interviewees emphasized cross-departmental training, detailed manuals, and legal education to improve infectious disease response capabilities.

This study employed focus group interviews (FGIs) to evaluate the preparedness and training requirements for an emerging infectious disease response system in the Republic of Korea.Based on the FGIs, the critical role of interdepartmental cooperation in responding to emerging infectious diseases was identified, with agencies such as public health centers, police, and fire services playing key roles in scene control, decontamination, and patient transport. Frequent staff turnover and a lack of trained personnel at local government levels were significant challenges, necessitating the development of training materials for unskilled workers. Civil complaints, common during outbreaks, require public officials to be educated on legal frameworks and the management of patients’ rights. The absence of standardized procedures for managing patients, such as bed assignments considering underlying conditions and sample collection, underscores the need for comprehensive guidelines.Interviewees emphasized cross-departmental training, detailed manuals, and legal education to improve infectious disease response capabilities.

BACKGROUND AND PURPOSE: The anti-John-Cunningham virus (JCV)-antibody serostatus and index are used in the risk stratification of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients treated with natalizumab. However, little information on these parameters is available for Asian countries. The purpose of this study was to determine the rate of seropositivity, index, and longitudinal index evolution in Korean patients with MS. METHODS: The antibody seroprevalence was analyzed in 355 samples from 187 patients with clinically isolated syndrome or MS using a second-generation, two-step, enzyme-linked immunosorbent assay. A 4-year longitudinal evaluation was applied to 66 patients. RESULTS: The overall antibody seroprevalence was 80% (n=149). Among antibody-positive patients, the index had a median value of 3.27 (interquartile range, 1.52–4.18), with 77% (n=114) and 56% (n=83) of patients having indices >1.5 and >3.0, respectively. The serostatus of 59 (89%) of the 66 patients did not change during the longitudinal analysis, while 3 (6%) of the 53 patients who were initially seropositive reverted to seronegativity, and 2 (15%) of the 13 patients who were initially seronegative converted to seropositivity. All patients with a baseline index >0.9 maintained seropositivity, and 92% of patients with a baseline index >1.5 maintained this index over 4 years. No patients developed PML (median disease duration, 8 years). CONCLUSIONS: The seroprevalence and index of anti-JCV antibodies in Korean patients with MS may be higher than those in Western countries.
Antibodies ; Asia ; Asian Continental Ancestry Group ; Enzyme-Linked Immunosorbent Assay ; Humans ; JC Virus ; Leukoencephalopathy, Progressive Multifocal ; Multiple Sclerosis ; Natalizumab ; Seroepidemiologic Studies

The authors hope to add the Acknowledgements, which have been omitted from the initial manuscript. Also, the authors hope to revise the Conflict of Interest.

Two Domestic Korean Shorthair cats presented with dyschezia and vomiting. Computed tomography revealed a colonic mass with calcification and lymph node metastasis in case 1, and a small intestinal mass with disseminated mesenteric metastasis and calcification in case 2. Histopathology revealed intestinal adenocarcinoma with osseous metaplasia. Case 1 died two months after surgery from distant metastasis; and case 2 showed no metastasis for five months but presented with anorexia, euthanized seven months after diagnosis. Metastatic intestinal adenocarcinoma with bone formation should be considered as differential diagnosis for calcification on imaging, and lymph node metastasis at diagnosis may indicate poor prognosis.

Purpose: Cystic duct cancers (CDCs) have been classified as extrahepatic bile duct cancers or gallbladder cancers (GBCs); however, it is unclear whether their clinical behavior is similar to that of distal extrahepatic bile duct cancers (DBDCs) or GBCs. Materials and Methods: T category of the CDCs was classified using current T category scheme of the GBCs and DBDCs, and clinicopathological factors were compared among 38 CDCs, 345 GBCs, and 349 DBDCs. We modified Nakata’s classifications (type 1, confined within cystic duct [CD]; combined types 2-4, extension beyond CD) and compared them. Results: No significant overall survival (OS) difference was observed between the patients with CDC, GBC, and DBDC. The T category of GBC staging was more accurate at distinguishing OS in patients with CDC than the DBDC staging. Patients with T3 CDC and GBC showed a significant OS difference when using the T category for GBC staging, while those with T1-T2 CDC and GBC showed no significant difference. In contrast, the T category of DBDC staging did not show any significant OS difference between patients with T1-T2 CDC and DBDC or T3 CDC and DBDC. Patients with type 1 CDC had significantly better OS than those with combined types. Conclusion Unlike GBCs and DBDCs, CDCs exhibit distinct clinicopathological characteristics. The OS is better when the CDC confines within the CD, compared to when it extends beyond it. Therefore, we propose a new T category scheme (T1, confined to CD; T2, invaded beyond CD) for better classifying CDCs.

Purpose: Cystic duct cancers (CDCs) have been classified as extrahepatic bile duct cancers or gallbladder cancers (GBCs); however, it is unclear whether their clinical behavior is similar to that of distal extrahepatic bile duct cancers (DBDCs) or GBCs. Materials and Methods: T category of the CDCs was classified using current T category scheme of the GBCs and DBDCs, and clinicopathological factors were compared among 38 CDCs, 345 GBCs, and 349 DBDCs. We modified Nakata’s classifications (type 1, confined within cystic duct [CD]; combined types 2-4, extension beyond CD) and compared them. Results: No significant overall survival (OS) difference was observed between the patients with CDC, GBC, and DBDC. The T category of GBC staging was more accurate at distinguishing OS in patients with CDC than the DBDC staging. Patients with T3 CDC and GBC showed a significant OS difference when using the T category for GBC staging, while those with T1-T2 CDC and GBC showed no significant difference. In contrast, the T category of DBDC staging did not show any significant OS difference between patients with T1-T2 CDC and DBDC or T3 CDC and DBDC. Patients with type 1 CDC had significantly better OS than those with combined types. Conclusion Unlike GBCs and DBDCs, CDCs exhibit distinct clinicopathological characteristics. The OS is better when the CDC confines within the CD, compared to when it extends beyond it. Therefore, we propose a new T category scheme (T1, confined to CD; T2, invaded beyond CD) for better classifying CDCs.

Purpose: Cystic duct cancers (CDCs) have been classified as extrahepatic bile duct cancers or gallbladder cancers (GBCs); however, it is unclear whether their clinical behavior is similar to that of distal extrahepatic bile duct cancers (DBDCs) or GBCs. Materials and Methods: T category of the CDCs was classified using current T category scheme of the GBCs and DBDCs, and clinicopathological factors were compared among 38 CDCs, 345 GBCs, and 349 DBDCs. We modified Nakata’s classifications (type 1, confined within cystic duct [CD]; combined types 2-4, extension beyond CD) and compared them. Results: No significant overall survival (OS) difference was observed between the patients with CDC, GBC, and DBDC. The T category of GBC staging was more accurate at distinguishing OS in patients with CDC than the DBDC staging. Patients with T3 CDC and GBC showed a significant OS difference when using the T category for GBC staging, while those with T1-T2 CDC and GBC showed no significant difference. In contrast, the T category of DBDC staging did not show any significant OS difference between patients with T1-T2 CDC and DBDC or T3 CDC and DBDC. Patients with type 1 CDC had significantly better OS than those with combined types. Conclusion Unlike GBCs and DBDCs, CDCs exhibit distinct clinicopathological characteristics. The OS is better when the CDC confines within the CD, compared to when it extends beyond it. Therefore, we propose a new T category scheme (T1, confined to CD; T2, invaded beyond CD) for better classifying CDCs.